Tamoxifen treatment of breast cancer cells : Impact on Hedgehog/GLI1 signaling

The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the...

Descripción completa

Detalles Bibliográficos
Autores Principales: Villegas, Victoria E., Rondón Lagos, Milena, Annaratone, Laura, Castellano, isabella, Grismaldo, Adriana, Sapino, Anna, Zaphiropoulos, Peter
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2016
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/21353
https://doi.org/10.3390/ijms17030308